Publications by authors named "Jason A Roberts"

Claim this Profile
E
Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
Eva Benavent, Jaime Lora-Tamayo, Marta Ulldemolins, Paula Pons-Oltra, Matthieu Gregoire, Jason A Roberts

Antimicrob Agents Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefazolin pharmacokinetics during prolonged intermittent kidney replacement therapy.
Jessica H Xu, Sam Salman, David Jr Morgan, Hayoung Won, Steven C Wallis, Jason A Roberts

Anaesth Intensive Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterial Pharmacokinetics in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review of Population Pharmacokinetic Studies.
Chanelle Ren, Frank Huang, Vesa Cheng, Jiao Xie, Jason A Roberts

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation.
Kelly A Cairns, Maria Patricia Hernandez-Mitre, Trisha N Peel, Iain J Abbott, David M Kaye, Jason A Roberts

Clin Pharmacokinet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Research Agenda on Adult Extracorporeal Membrane Oxygenation Using the Delphi Method: A Position Paper of the Extracorporeal Membrane Oxygenation Pharmacology Network.
Diana Morales Castro, Abdulrahman Abdullah Al-Fares, Gianluca Paternoster, Haifa Lyster, Benjamin Hohlfelder, Jason A Roberts

Crit Care Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the numbers: do nomograms capture the complexity of RRT dosing? Author's reply.
Manuel Colmenero, Jason A Roberts, Jeffrey Lipman, Marta Ulldemolins

Intensive Care Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic residual drug error in the intensive care unit: A qualitative exploration of awareness, causes, and solutions.
Paul Jarrett, Fiona M Coyer, Debbie Long, Jason A Roberts, Samantha Keogh

Aust Crit Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of an Ex Vivo Pediatric Extracorporeal Membrane Oxygenation Circuit on Sequestration of Antimicrobials.
Michele L Cree, Mohd Hafiz Abdul-Aziz, Emma Haisz, Steven C Wallis, Hayoung Won, Jason A Roberts

Crit Care Explor· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of the global epidemiology of carbapenem-resistant Escherichia coli.
Mikaela M Walker, Jason A Roberts, Yixuan Li, Fekade B Sime

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia.
Julia Laporte-Amargos, Marta Ulldemolins, María Patricia Hernández-Mitre, Jason A Roberts, Raul Rigo-Bonnin

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation.
Midori Nakagaki, Krispin Hajkowicz, Jason A Roberts, Andrea S Henden

Expert Rev Anti Infect Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing epidemiology of species in Asia Pacific and evidence for optimizing antifungal dosing in challenging clinical scenarios.
Yee-Chun Chen, Sohita Dhillon, Nicholas Adomakoh, Jason A Roberts

Expert Rev Anti Infect Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of blood culture time-to-positivity as a pharmacodynamic indicator for monitoring antibiotic therapy against MDR Gram-negative bacteria.
Irene Zaghi, Monica Cricca, Jason A Roberts, Martina Brandolini, Claudia Colosimo

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials.
Yixuan Li, Jason A Roberts, Mohd H Abdul-Aziz, Fekade B Sime

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of outpatient parenteral antimicrobial therapy program in the contemporary health care system: A narrative review of the evidence.
Solomon Ahmed Mohammed, Natasha Roberts, David Nicolás, Sean Unwin, Menino Cotta, Jason A Roberts

J Infect Public Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic therapy for severe bacterial infections.
Jean-François Timsit, Lowell Ling, Etienne de Montmollin, Hendrik Bracht, Andrew Conway-Morris, Jason A Roberts

Intensive Care Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects.
María Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit, David C Griffith, Jason A Roberts

Antimicrob Agents Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fluconazole population pharmacokinetics study to improve target attainment in critically ill patients.
My-Luong Vuong, Omar Elkayal, Ruth Van Daele, Jan-Willem C Alffenaar, Sophie L Stocker, Jason A Roberts

Infection· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairment.
Helmi Sulaiman, Muhammad Azrai Rozali, Santosh K S Adiraju, M Shahnaz Hasan, Janattul A Jamal, Jason A Roberts

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of cefazolin administered as prophylaxis in paediatric patients undergoing cardiac surgery.
Vesa Cheng, Jessica Suna, Xin Liu, Gregory Moloney, Supreet P Marathe, Jason A Roberts

Anaesth Crit Care Pain Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.
Jason A Roberts, Marta Ulldemolins, Xin Liu, João P Baptista, Irma Bilgrami, Darren M Roberts, Michael S Roberts

Intensive Care Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Network of Antibiotic Allergy Nations (iNAAN): Protocol for a type 2 hybrid effectiveness-implementation multicentre prospective cohort and target trial emulation study evaluating penicillin allergy delabeling via direct oral challenge.
Elise A Mitri, Luke R Fletcher, Camille Paynter, Sara Vogrin, Fiona James, Jason A Roberts

PLoS One· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding the optimal regimen for treatment (FORT) in people with pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial.
Tiffany Jong, Timothy Baird, Helen Louise Barr, Scott Bell, Theophile Bigirumurame, Jason A Roberts

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles.
Ankit Dodla, Magdalena Giergiel, Aaron Mclean, Kamila Kochan, Linda Earnest, Jason A Roberts

Anal Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marginal cytokine modulation by Schistosoma mansoni soluble egg antigen in SARS-CoV-2-infected K18-hACE2 mice.
Yi Mu, Kexin Yan, Donald P McManus, Wilson Nguyen, Daniel J Rawle, Jason A Roberts

Folia Parasitol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis